Skip to content
ING THINK

India: from generics giant to innovation powerhouse?

Share

From the original

ASIA/PACIFIC: India is the most dominant generics manufacturer in the world. Given the increased importance and complexity of generics and the recent free trade deal with the EU, the sector’s outlook is bright. However, India’s push into innovation is unlikely to lead to blockbus

Related speeches

4 items

More from ING THINK

5 items

FX Bank Forecast aggregates and synthesises central-bank commentary. Sentiment scoring and bank tagging are heuristic — verify against the original source before trading. We do not endorse third-party content.

FX BANK FORECAST · COVERAGE

Institutional FX coverage in your inbox

Aggregated year-end forecasts, scenario shifts, and curated analyst notes from eight institutional desks. No promotion.